0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2004;291(8):913. doi:10.1001/jama.291.8.913.
Text Size: A A A
Published online

COMBINATION THERAPY TO LIMIT INFARCT SIZE

The best pharmacologic strategy to prevent progression of acute myocardial infarction (AMI) in patients awaiting percutaneous coronary intervention (PCI) is not clear. Kastrati and colleaguesArticle conducted an open-label, randomized trial of patients with AMI to determine whether a combined regimen of abciximab—an antiplatelet agent—plus reteplase—a fibrinolytic agent—prior to PCI would result in less myocardial damage than that with abciximab alone. Several hours after drug administration, patients receiving combination therapy had superior blood flow through the involved vessel, but final infarct size did not differ between the 2 groups. In an editorial, LincoffArticle discusses pharmacologic and interventional therapies for myocardial preservation and the benefits and risks of combining the 2 approaches.

HOME BLOOD PRESSURE MONITORING TO ADJUST TREATMENT

The value of self-measured, home blood pressure monitoring to adjust hypertension treatment is not known. Staessen and colleagues randomized patients with diastolic hypertension to either multiple daily home measurements for a week or physician office measurement. Results were reviewed at bimonthly office visits and treatment adjustments were made by a physician blinded to study assignment. After a year of follow-up, patients monitoring at home were more likely to have stopped antihypertensive medications, incurring slightly lower hypertension-related health care costs. The 2 groups experienced no differences in left ventricular mass or overall feelings of well-being, but the home-monitored patients had higher systolic and diastolic measurements at study end.

PREVENTING MIGRAINE WITH TOPIRAMATE

Results of several open-label and small, placebo-controlled studies suggest that the antiepileptic drug topiramate may be effective in preventing migraine headaches. Brandes and colleagues conducted a randomized controlled trial testing topiramate in patients experiencing an average of 3 to 12 migraines a month. They found that compared with patients receiving placebo, patients receiving either 100 or 200 mg/d of topiramate experienced a significant reduction in migraine frequency within the first month of treatment and had no loss of effect over the 26-week study; they also experienced significantly fewer days of migraine per month and required less rescue medication. Paresthesia, nausea, and fatigue were the most frequently reported adverse events, leading some patients to drop out of the study.

CHARACTERISTICS OF DUPLICATE PUBLICATION

Duplicate publications are articles with substantially similar content, but little is known about specific characteristics of these published articles. von Elm and colleagues systematically reviewed articles in the analgesia and anesthesia literature to categorize patterns of duplicate publication and to describe characteristics of publication, including journal impact factor, citation rates, and the time elapsed between publication of a duplicate and its main article. Six categories of duplicate publication were identified; duplicates were published in journals with slightly lower impact factors and an average of a year after publication of the main article, but duplicates and main articles had comparable citation rates.

A PIECE OF MY MIND

"Poor patient-physician communication definitely leads to irritability, probably on both sides." From "Irritability (Yours and Theirs)."

MEDICAL NEWS & PERSPECTIVES

Use of preimplantation genetic diagnosis is raising complex ethical issues.

EAR PIERCING INFECTIONS

Risks associated with ear cartilage piercing are highlighted in an investigation of Pseudomonas aeruginosa infections in clients of a piercing establishment in Oregon.

CLINICIAN'S CORNER

Part 1Article of this 2-part article reviews factors associated with urinary incontinence in women and various treatment options. Part 2Article details patient assessment and treatment concerns through discussion of 2 illustrative cases.

BIOTECHNOLOGY IN MEDICINE

Authors are invited to submit manuscripts for a theme issue about Medical Applications of Biotechnology.

JAMA PATIENT PAGE

For your patients: Information about body piercing.

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.